Eloxx Pharmaceuticals Inc (OTC Pink - Current Information:ELOX)
| 0.95 Delayed Data As of Dec 08 |  -0.04 / -4.04%Today’s Change | 0.94 Today|||52-Week Range 10.90 | -47.80% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 75.0K | 75.0K | 0.00 | 0.00 | |
| Depreciation And Amortization | 177.1K | 93.4K | 39.0K | 216.0K | ||
| Operating Expenses | Gross Income | -- | -18.4K | -39.0K | -216.0K | |
| General Expenses | 7.7M | 3.5M | 20.4M | 46.8M | ||
| Other Operating Expenses | 258.7K | 181.4K | 0.00 | 0.00 | ||
| Research And Development | 4.8M | 2.1M | 16.4M | 20.5M | ||
| Total Operating Expenses | 8.2M | 3.8M | 20.4M | 47.0M | ||
| Non-Operating Expenses | Operating Income | -8.1M | -3.7M | -20.4M | -47.0M | |
| Extraordinary Credit | 458.4K | 2.2M | 0.00 | 0.00 | ||
| Extraordinary Charge | -10.4M | -7.5M | 0.00 | -594.0K | ||
| Interest Expense On Debt | 0.00 | 0.00 | 668.0K | 7.0K | ||
| Other Expenses | -2.8K | -530.00 | -156.0K | -92.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -18.1M | -8.9M | -21.2M | -47.1M | |
| Income Taxes | 0.00 | -680.0K | 0.00 | -122.0K | ||
| Preferred Dividend | -838.9K | -179.2K | -2.4M | 0.00 | ||
| Net Income | -18.1M | -8.3M | -21.2M | -47.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 720.9K | 1.0M | 5.0M | 32.4M | |
| Shares To Calculate EPS Diluted | 720.9K | 1.0M | 5.0M | 32.4M | ||
| Earnings Per Share | EPS | -$26.20 | -$8.40 | -$4.75 | -$1.45 | |
| EPS Diluted | -$26.20 | -$8.40 | -$4.75 | -$1.45 | ||
